Skip to main content

Table 1 Patients demographic data

From: A comparison of ondansetron and lidocaine in reducing injection pain of propofol: a randomized controlled study

  Group O (n = 80) Group L (n = 80) Group C (n = 80) P-value
Age (years); median(IQR) 52 (42.8–57.0) 49.5 (38.8–57.0) 47.5 (32.0–58.0) 0.199
Gender
  Male; n (%) 22 (27.5) 24 (30.0) 22 (27.5) 0.921
  Female; n (%) 58 (72.5) 56 (70.0) 58 (72.5)  
Weight (kg.); median (IQR) 63.5 (56.8–70.0) 65.5 (60.0–71.2) 66 (57.8–74.0) 0.255
Height (cm.); mean (SD) 159.3 (± 8.7) 160.9 (± 7) 160.8 (± 8.9) 0.406
BMI (kg/m2); median (IQR) 25.1 (22.8–28.2) 26.2 (23.3–28.5) 24.9 (22.7–29.2) 0.618
ASA Classification; n (%)
  ASA class I 10 (12.5) 12 (15.0) 11 (13.8)  
  ASA class II 60 (75.0) 56 (70.0) 58 (72.5) 0.973
  ASA class III 10 (12.5) 12 (15.0) 11 (13.8)  
Baseline; median (IQR)
  Pulse rate (bpm) 72.5 (65.8–84.0) 75.0 (67.0–85.0) 75.0 (65.0–83.5) 0.665
  SBP (mmHg.) 138.5 (125.8–158.2) 145.0 (128.0–160.2) 134.5 (120.0–155.0) 0.247
  DBP (mmHg.) 80.0 (70.0–88.2) 81.5 (72.0–90.0) 77.0 (70.0–83.2) 0.066
  MAP (mmHg.) 96.5 (87.0–110.0) 101.0 (91.8–109.2) 95.0 (85.8–102.2) 0.046
Before induction; median (IQR)
  Pulse rate (bpm.) 70.0 (62.0–81.2) 70.0 (63.8–80.0) 70.0 (60.0–87.2) 0.878
  SBP (mmHg.) 121.0 (105.0–140.0) 117.0 (105.0–131.2) 119.5 (96.0–140.0) 0.378
  DBP (mmHg.) 78.0 (60.0–85.0) 70.0 (60.0–81.0) 70.0 (55.0–80.0) 0.295
  MAP (mmHg.) 87.5 (74.8–100.2) 82.0 (74.0–95.2) 87.5 (66.0–100.0) 0.472
After intubation; median (IQR)
  Pulse rate (bpm.) 76.5 (67.8–85.0) 83.0 (70.0–95.0) 75.0 (67.8–88.2) 0.027
  SBP (mmHg.) 136.0 (123.8–160.8) 140.0 (123.8–168.8) 130.5 (112.5–155.2) 0.071
  DBP (mmHg.) 80.0 (73.5–95.0) 84.0 (67.8–101.2) 78.0 (64.8–90.0) 0.066
  MAP (mmHg.) 98.0 (87.5–113.2) 102.5 (85.0–122.0) 92.5 (78.8–107.2) 0.012